Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch
Executive Summary
Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market
You may also be interested in...
Allegra Ads Cited For Superiority Claims; Zyrtec Data Stronger, FDA Says
FDA is challenging Aventis' TV and print advertisements for Allegra on the grounds that they imply the product is superior to other antihistamines, FDA's ad division said
Allegra Ads Cited For Superiority Claims; Zyrtec Data Stronger, FDA Says
FDA is challenging Aventis' TV and print advertisements for Allegra on the grounds that they imply the product is superior to other antihistamines, FDA's ad division said
Formularies Should Stress Rx Compliance, Not Co-Pays, Pitney Bowes Says
Covering chronic disease medications as tier one to encourage patient compliance can help manage health care costs, Pitney Bowes Manager-Employee Benefits Design & Development Christine Berman said